Bleakley Financial Group, LLC Liquidia Corp Transaction History
Bleakley Financial Group, LLC
- $3.32 Trillion
- Q4 2024
A detailed history of Bleakley Financial Group, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 23,785 shares of LQDA stock, worth $385,317. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,785
Previous 25,692
7.42%
Holding current value
$385,317
Previous $257 Million
8.87%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding LQDA
# of Institutions
188Shares Held
44.2MCall Options Held
1.48MPut Options Held
1.14M-
Black Rock Inc. New York, NY4.24MShares$68.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$57.6 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$53.3 Million0.21% of portfolio
-
Findell Capital Management LLC New York, NY3.08MShares$49.9 Million14.82% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.27MShares$36.7 Million1.69% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.04B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...